Samsara Bio Capital, LLC Amryt Pharma PLC Transaction History

Samsara Bio Capital, LLC

  • $173 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.0 - $14.7 $0 - $4.48 Million
-304,715 Closed
0 $0
Q1 2023

May 15, 2023
BUY
$7.0 - $14.77 $2.13 Million - $4.5 Million
304,715 New
304,715 $4.44 Million
Q2 2022

Aug 15, 2022
BUY
$6.85 - $8.87 $171,250 - $221,749
25,000 Added 8.94%
304,715 $2.13 Million
Q1 2022

May 16, 2022
BUY
$6.3 - $10.86 $1.76 Million - $3.04 Million
279,715 New
279,715 $2.31 Million

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email